The amount of weight individuals can lose on tirzepatide is comparable to that achieved through surgical weight loss interventions without downtime or risk of complications
doi: 10.1111/ene.15040 60 MandalSBarnettJBrillSEBrownJSDennenyEKHareSSet al
The transition from oral to injectable tirzepatide typically involves starting at the lowest injectable dose and titrating up following standard protocols, regardless of what oral dose you were taking previously
Phase I trials, historically referred to as toxicity trials, test a new drug in a small number of participants to identify the dose range and the drugs safety profile [16, 37]
It is important to highlight that CSF2 and CXCL10 encode pro-inflammatory proteins linked to neurodegenerative diseases 51,52,53 , and, as mentioned above, elevated levels of CXCL10 protein are associated with persistent VCD in individuals from the same cohort of the present study 20